- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Telangiectasis"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Telangiectasis" (29 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03319849 | Recruiting | A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
112 | All | 21 Years to 80 Years (Adult, Senior) | NCT03319849 | NTMT-03-B | February 6, 2018 | October 16, 2019 | October 16, 2019 | October 24, 2017 | April 17, 2018 |
|
||
2 | NCT03316300 | Recruiting | A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
112 | All | 21 Years to 80 Years (Adult, Senior) | NCT03316300 | NTMT-03-A | November 24, 2017 | October 16, 2019 | October 16, 2019 | October 20, 2017 | April 9, 2018 |
|
||
3 | NCT03397004 | Not yet recruiting | Doxycycline for Hereditary Hemorrhagic Telangiectasia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03397004 | 160517448 Award Number W81XWH-17-1-0429 |
HHT | May 2018 | December 2020 | December 2020 | January 11, 2018 | April 13, 2018 | ||
4 | NCT03227263 | Recruiting | BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). |
|
|
Interventional | Phase 3 |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT03227263 | 69HCL17_0018 | BABH | September 28, 2017 | March 2020 | March 2020 | July 24, 2017 | October 18, 2017 |
|
|
5 | NCT01752049 | Recruiting | Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT01752049 | BVMC 6207 2U54NS065705-06 |
May 2013 | June 2019 | June 2019 | December 18, 2012 | May 18, 2017 |
|
||
6 | NCT03152019 | Recruiting | Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT03152019 | 69HCL16_0705 | TACRO | May 22, 2017 | January 2019 | January 2019 | May 12, 2017 | October 18, 2017 |
|
|
7 | NCT01158807 | Recruiting | Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia |
|
Observational |
|
Other / NIH |
|
|
1800 | All | Child, Adult, Senior | NCT01158807 | RDCRN# 6203 1U54NS065705 |
BVMN6203 | April 2010 | August 2019 | August 2019 | July 8, 2010 | May 18, 2017 |
|
|||
8 | NCT00230620 | Recruiting | Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families |
|
Observational |
|
Other |
|
250 | All | Child, Adult, Senior | NCT00230620 | IC/CLS1 | December 1998 | November 2018 | November 2020 | October 3, 2005 | May 29, 2015 |
|
|||||
9 | NCT02246491 | Recruiting | Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 3 Years to 100 Years (Child, Adult, Senior) | NCT02246491 | J1491 IRB00038916 |
September 2014 | September 2017 | September 2018 | September 22, 2014 | March 24, 2016 |
|
||
10 | NCT03321916 | Recruiting | MacTel Laser Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
12 | All | 21 Years to 79 Years (Adult, Senior) | NCT03321916 | MacTelLaser1 | October 2017 | December 2019 | December 2019 | October 26, 2017 | October 26, 2017 |
|
||
11 | NCT03357978 | Recruiting | Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 2 Years to 45 Years (Child, Adult) | NCT03357978 | InfectionandLiver_AT2016 | October 1, 2016 | September 30, 2018 | September 30, 2019 | November 30, 2017 | November 30, 2017 |
|
||
12 | NCT02977637 | Recruiting | MRA With Feraheme in HHT |
|
|
Interventional | Phase 1 |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT02977637 | 15-001308 | November 2016 | November 2017 | November 2017 | November 30, 2016 | March 30, 2017 |
|
||
13 | NCT02287558 | Recruiting | Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study |
|
|
Interventional | Phase 1 |
|
Other |
|
|
9 | All | 18 Years and older (Adult, Senior) | NCT02287558 | CASE4Z14 | January 27, 2015 | June 2018 | December 2018 | November 10, 2014 | January 25, 2018 |
|
||
14 | NCT02963129 | Not yet recruiting | Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT |
|
|
Interventional | Phase 3 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02963129 | 2666 | June 2017 | June 2017 | December 2017 | November 15, 2016 | November 15, 2016 |
|
||
15 | NCT02936349 | Recruiting | Graded TTCE for Post-Embolization PAVM Monitoring |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 89 Years (Adult, Senior) | NCT02936349 | 825381 | October 2016 | October 2018 | October 2019 | October 18, 2016 | February 16, 2018 |
|
|||
16 | NCT02638012 | Recruiting | Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT02638012 | 15-057 | December 2015 | December 2018 | February 2019 | December 22, 2015 | April 18, 2018 |
|
||
17 | NCT02983253 | Recruiting | Immunmodulation in Patients With HHT |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT02983253 | ImmunUHEssen | June 2016 | September 2018 | December 2018 | December 6, 2016 | December 8, 2016 |
|
|||
18 | NCT03472859 | Recruiting | Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03472859 | R17111 | October 1, 2017 | December 2018 | December 2018 | March 21, 2018 | March 21, 2018 |
|
||
19 | NCT02770807 | Recruiting | EDS in Ataxia Telangiectasia Patients |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
180 | All | 6 Years and older (Child, Adult, Senior) | NCT02770807 | IEDAT-02-2015 | ATTeST | March 2, 2017 | August 2018 | March 2019 | May 12, 2016 | October 31, 2017 |
|
|
20 | NCT02857894 | Recruiting | Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated) |
|
Observational |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02857894 | MMT_2015_4 | ATM | November 5, 2015 | May 2018 | May 2018 | August 5, 2016 | March 1, 2018 |
|
|||
21 | NCT01975103 | Recruiting | Endpoint Management Software for Photothermal Stimulation of Macular Diseases |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 100 Years (Adult, Senior) | NCT01975103 | EPM-001 | EPM | March 2013 | April 2018 | November 4, 2013 | May 4, 2017 |
|
||
22 | NCT02389959 | Recruiting | Intranasal Bevacizumab for HHT-Related Epistaxis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02389959 | 29501 | August 2014 | September 2018 | March 2019 | March 17, 2015 | April 27, 2017 |
|
||
23 | NCT02458703 | Not yet recruiting | Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 16 Years to 80 Years (Child, Adult, Senior) | NCT02458703 | CLS 2015/1 15/LO/0598 |
ExercisePAVM2 | May 2015 | May 2018 | May 2018 | June 1, 2015 | June 1, 2015 | ||
24 | NCT01793168 | Recruiting | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford |
|
Observational |
|
Other |
|
|
20000 | All | Child, Adult, Senior | NCT01793168 | 03-10-014 Hypersomnia Foundation National Ataxia Foundation 4p- Support Group CdLS Foundation Hyperacusis Research Limited Kabuki Syndrome Network Kawasaki Disease Foundation Klippel-Feil Syndrome Freedom Leiomyosarcoma Direct Research MSS Support Group ML4 Foundation Stickler Involved People IWSA Soft Bones PWN4PWN aHUS Klippel-Feil Syndrome Alliance American MEN Support Kleine-Levin Syndrome All Things Kabuki WSS Foundation BIVA ABDA PROS Foundation (HLH) |
CoRDS | July 2010 | December 2100 | December 2100 | February 15, 2013 | October 2, 2017 |
|
|||
25 | NCT01856842 | Recruiting | Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT01856842 | 01-ANGIO-12 | April 2013 | April 2018 | April 2018 | May 17, 2013 | May 18, 2017 |
|
||
26 | NCT03423628 | Recruiting | A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
132 | All | 18 Years and older (Adult, Senior) | NCT03423628 | D6940C00002 2017-002451-28 135803 |
April 2, 2018 | April 5, 2021 | April 5, 2021 | February 6, 2018 | April 24, 2018 |
|
||
27 | NCT00874783 | Recruiting | Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases |
|
Observational |
|
Other |
|
120 | All | 18 Years and older (Adult, Senior) | NCT00874783 | 0599-08-HMO-CTIL | April 2009 | December 2025 | December 2025 | April 3, 2009 | November 28, 2017 |
|
|||||
28 | NCT02620254 | Recruiting | Mast Cell Connect: A Registry for Patients With Mastocytosis |
|
Observational |
|
Industry |
|
|
200 | All | Child, Adult, Senior | NCT02620254 | Mastocytosis Registry | November 2015 | December 2020 | December 2020 | December 2, 2015 | September 20, 2017 |
|
||||
29 | NCT02000089 | Recruiting | The Cancer of the Pancreas Screening-5 CAPS5)Study |
|
|
Observational |
|
Other / Industry |
|
|
2500 | All | 18 Years and older (Adult, Senior) | NCT02000089 | NA_00087754 | CAPS5 | January 2014 | October 2021 | December 2023 | December 3, 2013 | December 7, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.